CT
BIIB icon

Cambridge Trust’s Biogen BIIB Stock Holding History

Cambridge Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$72.2K Hold
335
– – ﹤0.01% 387
2023
Q4 		$86.7K Hold
335
– – ﹤0.01% 356
2023
Q3 		$86.1K Hold
335
– – ﹤0.01% 360
2023
Q2 		$95.4K Sell
335
-62
-16% -$18.5K ﹤0.01% 360
2023
Q1 		$110K Hold
397
– – 0.01% 338
2022
Q4 		$110K Sell
397
-2
-0.5% -$565 ﹤0.01% 350
2022
Q3 		$107K Buy
399
+2
+0.5% +$425 0.01% 350
2022
Q2 		$81K Buy
397
+62
+19% +$12.7K ﹤0.01% 417
2022
Q1 		$71K Sell
335
-33
-9% -$7.18K ﹤0.01% 478
2021
Q4 		$88K Buy
+368
New +$94.6K ﹤0.01% 436

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cambridge Trust's BIIB Position: Q1 2024 in Review

Cambridge Trust held its Biogen (BIIB) position steady in Q1 2024 at 335 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

Cambridge Trust first reported a position in BIIB in Q4 2021 and has held it in 10 quarters since. The position peaked at $110K in Q1 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Cambridge Trust held 335 shares of Biogen worth $72.2K as of Q1 2024.
  • Cambridge Trust left its Biogen share count unchanged in Q1 2024.
  • Biogen made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #387 holding.
  • Cambridge Trust first reported a position in Biogen in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Biogen position peaked at $110K in Q1 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.